Four different treatment strategies in aggressive fibromatosis: A systematic review

被引:19
|
作者
Seinen, Jojanneke M. [1 ]
Niebling, Maarten G. [1 ]
Bastiaannet, Esther [2 ,3 ]
Pras, Betty [4 ]
Hoekstra, Harald J. [1 ]
机构
[1] Univ Groningen, Dept Surg Oncol, Univ Med Ctr Groningen, Groningen, Netherlands
[2] Leiden Univ, Dept Surg, Med Ctr, Leiden, Netherlands
[3] Leiden Univ, Dept Gerontol & Geriatr, Med Ctr, Leiden, Netherlands
[4] Univ Groningen, Dept Radiat Oncol, Univ Med Ctr Groningen, Groningen, Netherlands
关键词
Aggressive fibromatosis; Different treatment strategies; Systematic review;
D O I
10.1016/j.ctro.2018.03.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The treatment approach for aggressive fibromatosis is changing. Although surgery is the mainstay in common practice, recent literature is reporting a more conservative approach. We compared the local control rate for surgery, surgery with radiotherapy, radiotherapy alone and a wait and see policy in a systematic review. Methods: A comprehensive search of the databases PubMed/Medline, Embase and Cochrane, of the medical literature published in 1999 till March 2017 was performed by two reviewers, including articles about extra abdominal aggressive fibromatosis without the genetical variants. A total of 671 studies were assessed for eligibility, and 37 studies were included for analysis, representing 2780 patients. Results: The local control rates for surgery alone, surgery and radiotherapy, radiotherapy alone and observation were 75%, 78%, 85% and 78%, respectively. For patients with recurrent disease observation had a better local control rate than surgery alone (p = 0.001). In the observation group, stabilization of the tumor was seen in median 14 (range 12-35) months. The time to local recurrence in the treatment group was median 17 (range, 11-52) months. Conclusion: A watchful conservative first line approach with just observation and closely monitoring, by means of physical examination and MRI, appears to be justified in a subgroup of patients without clinical symptoms and no possible health hazards if the tumor would progress. (C) 2018 The Authors. Published by Elsevier B.V.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 50 条
  • [1] The pharmacological treatment of aggressive fibromatosis: a systematic review
    Janinis, J
    Patriki, M
    Vini, L
    Aravantinos, G
    Whelan, JS
    ANNALS OF ONCOLOGY, 2003, 14 (02) : 181 - 190
  • [2] Systemic Treatment for Aggressive Fibromatosis
    Judson, I.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S91 - S91
  • [3] RADIOTHERAPY IN THE TREATMENT OF AGGRESSIVE FIBROMATOSIS
    HOFFMANN, W
    KORTMANN, RD
    BAMBERG, M
    ONKOLOGIE, 1994, 17 (06): : 609 - 609
  • [4] Radiotherapy in the multimodal treatment of aggressive fibromatosis -: own results and review of literature
    Micke, O
    Hesselmann, S
    Schäfer, U
    Hans, HT
    Bruns, F
    Willich, N
    Seegenschmiedt, MH
    RADIOTHERAPY AND ONCOLOGY, 2004, 71 : S38 - S39
  • [5] The role of radiotherapy in the treatment of aggressive fibromatosis
    Shin, KH
    Shin, SJ
    Lee, DH
    Kang, ES
    Suh, CO
    YONSEI MEDICAL JOURNAL, 1999, 40 (05) : 439 - 443
  • [6] Treatment of Aggressive Fibromatosis of the Head and Neck
    Sun, Guowen
    Xu, Mingyao
    Huang, Xiaofeng
    JOURNAL OF CRANIOFACIAL SURGERY, 2010, 21 (06) : 1831 - 1833
  • [7] Treatment of Aggressive Pelvic Fibromatosis With Interferon
    Arien, Femke
    Aleman, Jacomijntje M.
    op de Beeck, Bart
    Tjalma, Wiebren A. A.
    OBSTETRICS AND GYNECOLOGY, 2015, 126 (06): : 1219 - 1221
  • [8] Biology and Treatment of Aggressive Fibromatosis or Desmoid Tumor
    Skubitz, Keith M.
    MAYO CLINIC PROCEEDINGS, 2017, 92 (06) : 947 - 964
  • [9] Pazopanib, a promising option for the treatment of aggressive fibromatosis
    Szucs, Zoltan
    Messiou, Christina
    Wong, Han Hsi
    Hatcher, Helen
    Miah, Aisha
    Zaidi, Shane
    van der Graaf, Winette T. A.
    Judson, Ian
    Jones, Robin L.
    Benson, Charlotte
    ANTI-CANCER DRUGS, 2017, 28 (04) : 421 - 426
  • [10] The treatment of aggressive fibromatosis occurred in head and neck
    Cao, Jun
    Sun, Guowen
    Zhu, Feng
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2020, 126 : 141 - 142